Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease

Kidney and Blood Pressure Research

Volumn 21, Issue 1, 1998, Pages 59-65

  Pestana, Manuel ^a,b,d   Jardim, Helena ^c   Serrão, Paula ^b   Soares da Silva, Patricio ^b   Guerra, Levi ^a  

^a Department of Nephrology ^*  (Portugal)

^b Inst of Pharmacol and Therapeutics   (Portugal)

^c Institute of Pharmacology and Therapeutics   (Portugal)

^d Inst of Pharmacol and Therapeutics   (Portugal)

Author keywords

5 HIAA; Chronic renal insufficiency; DOPAC; Dopamine; HVA; L DOPA

Indexed keywords

3 O METHYLDOPAMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; AMINE; AMINE OXIDASE (FLAVIN CONTAINING); CATECHOL METHYLTRANSFERASE; CREATININE; DOPAMINE; HOMOVANILLIC ACID; LEVODOPA; PHOSPHATE; POTASSIUM; SODIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DEAMINATION; DOPAMINE METABOLISM; DOPAMINE URINE LEVEL; DOPAMINERGIC SYSTEM; EPITHELIUM CELL; FEMALE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY TUBULE EPITHELIUM; MALE; METHYLATION; PHOSPHATE INTAKE; POTASSIUM INTAKE; PRIORITY JOURNAL; SODIUM INTAKE; URINARY EXCRETION;

3,4-DIHYDROXYPHENYLACETIC ACID; ADULT; AGED; BIOPSY; CATECHOL O-METHYLTRANSFERASE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; CREATININE; DOPAMINE; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; KIDNEY TUBULES; LEVODOPA; MALE; MIDDLE AGED; MONOAMINE OXIDASE; PHOSPHATES; POTASSIUM; SODIUM;

EID: 0031780843     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025844     Document Type: Article

References (31)

1. Baines AD, Chan W: Production of urine free dopamine from dopa: A micropuncture study. Life Sci 1980;26:253-259.
2. Ball SG, Gunn IG, Douglas IH: Renal handling of dopa, dopamine, norepinephrine, and epinephrine in the dog Am J Physiol 1982; 242:F56-F62
3. Hagege J, Richet G: Proximal tubule dopamine histofluorescence in renal slices incubated with L-dopa. Kidney Int 1985;27.3-8.
4. Suzuki H, Nakane H, Kawamura M, Yoshizawa M, Takeshita E, et al: Excretion and metabolism of dopa and dopamine by isolated perfused rat kidney Am J Physiol 1985;247.E285-E290.
5. Hayashi M, Yamaji Y, Kitajima W, Saruta T: Aromatic L-amino acid decarboxylase activity along the rat nephron Am J Physiol 1990; 258 F28-F33
6. Soares-da-Silva P, Fernandes MH: Synthesis and metabolism of dopamine in the kidney. Effects of sodium chloride, monoamine oxidase inhibitors and alpha-human atrial natriuretic peptide Am J Hypertens 1990:3:7S-10S.
7. Soares-da-Silva P: Source and handling of renal dopamine: Its physiological importance News Physiol Sci 1994;9:128-134.
8. Zimlichman R, Levinson PD, Kelly G, Stull R, Keiser HR, et al. Derivation of urinary dopamine from plasma dopa. Clin Sci 1988;75:515-520
9. Lee MR. Dopamine and the kidney: Ten years on. Clin Sci 1993;84:357-375.
10. Fernandes MH, Pestana M, Soares-da-Silva P: Deamination of newly-formed dopamine in rat renal tissues. Br J Pharmacol 1991;102.778-782.
11. Fernandes MH, Soares-da-Silva P: Sequential involvement of monoamine oxidase and catechol-O-methyltransferase m the metabolism of newly-formed dopamine in rat renal tissues: in Soares-da-Silva P (ed): Cardiovascular and Renal Actions of Dopamine. London, Pergamon Press, 1993, pp 21-30.
12. Pestana M, Soares-da-Silva P. Effect of type A and B monoamine oxidase inhibition by Ro 41-1049 and Ro 19-6327 on dopamine outflow in rat kidney slices Br J Pharmacol 1994;113. 1269-1274.
13. Pestana M, Vieira-Coelho MA, Pinot-do-Ó PC, Fernandes MH, Soares-da-Silva P: Assessment of renal dopaminergic system activity during cyclosporine A administration m the rat. Br J Pharmacol 1995;115:1349-1358.
14. Soares-da-Silva P, Pestana M, Vieira-Coelho MA, Fernandes MH, Albino-Teixeira A: Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model. Br J Pharmacol 1995;114:1403-1413.
15. Yoshimura M, Komori T, Nishimura M, Habuchi Y, Fujita N, et al Diagnostic significance of dopamine estimation using plasma and urine in patients with adrenal and renal insufficiency, renal transplantation and hypertension. Hypertens Res 1995;18(suppl I):S87-S92.
16. Alfieri AB, Cubeddu LX: Effects of inhibition of serotonin synthesis on 5-hydroxyindolacetic acid excretion, in healthy subjects. J Clin Pharmacol 1995;34:153-157.
17. Kopin IJ. Catecholamine metabolism: Basic aspects and clinical significance Pharmacol Rev 1985;37.333-364.
18. Fernandes MH, Soares-da-Silva P: Effects of MAO-A and MAO-B selective inhibitors Ro 41-1049 and Ro 16-6327 on the deamination of newly formed dopamine in the rat kidney. J Pharmacol Exp Ther 1990;255:1309-1313
19. Fernandes MH, Soares-da-Silva P: Type A and B monoamine oxidase activities in the human and rat kidney. Acta Physiol Scand 1992;145: 363-367.
20. Vieira-Coelho MA, Fernandes MH, Soares-da-Silva P: In vivo effects of the monoamine oxidase inhibitors Ro 41-1049 and Ro 19-6327 on the production and fate of renal dopamine. J Neural Trans 1994;(suppl 41):365-370.
21. Vieira-Coeiho MA, Soares-da-Silva P: Ontogenic aspects of liver and kidney catechol-O-methyltransferase sensitivity to tolcapone Br J Pharmacol 1996;117:516-520.
22. Meister B, Bean AJ, Aperia A: Catechol-O-methyltransferase mRNA in the kidney and its appearance during ontogeny Kidney Int 1993; 44:726-733.
23. Gill J, Grossman E, Goldstein D: High urinary dopa excretion and low dopamine-to-dopa ratio in salt sensitive hypertension. Hypertension 1990;18:614-621.
24. +-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol 1987,252:F39-F45.
25. - exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Physiol 1990;259:F297-F303.
26. Alexander R, Gill J, Yamabe H, Lovenberg W, Keiser H: Effect of dietary sodium and of acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man. J Clin Invest 1974.54:194-200
27. Gill J, Gullner H, Lake C, Lakatua D, Lan G: Plasma and urinary catecholamines in salt sensitive idiopathic hypertension. Hypertension 1988;11:312-319.
28. Saito I, Takeshita E, Saruta T, Nagano S, Sekihara T: Urinary dopamine excretion in normotensive subjects with or without family history of hypertension. J Hypertens 1986,4:57-60
29. Koomans H, Roos J, Boer P, Geyskes G, Dorhout Mees E. Salt sensitivity of blood pressure in chronic renal failure: Evidence for renal control of body fluid distribution in man. Hypertension 1982;4:190-197.
30. Barendregt J, Florijn K, Muizert Y, Chang P: Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion. Nephrol Dial Transplant 1995;10:1332-1341.
31. Pestana M, Santos A, Correia F, Serrão P, Polónia J, et al: In patients with IgA nephropathy urinary excretion of dopamine correlates positively with blood pressure responses to sodium manoeuvres. Am J Hypertens 1997;10(4)II-184A.